Riskpilot← Back to searchSign inGet full accessSAMTALSLABORATORIET AB
ABActiveOrg 5594071069Assessorsgatan 18 FOther education n.e.c. · NACE 8559Est. 20220 employees
Revenue 2025
SEK 688K
+16% vs 2024
EBITDA margin
70.0%
+39% vs 2024
Equity ratio
41.6%
Financial strength
Net profit 2025
SEK 282K
+34% vs 2024
| Revenue | SEK 688K | +16% |
| EBITDA | SEK 482K | +39% |
| Net profit | SEK 282K | +34% |
| Total assets | SEK 822K | +4% |
| Equity | SEK 342K | -5% |
| Employees | 0 | — |
Legal name
SAMTALSLABORATORIET AB
Org number
5594071069
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
21 november 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva konsultverksamhet, medieproduktion och utbildning inom kommunikation och organisation. Därutöver ska bolaget äga och förvalta värdepapper för bolagets räkning samt bedriva med ovanstående förenlig verksamhet.
Address
Assessorsgatan 18 F
Email
emma.stenstrom@hhs.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 1 231 | 594 | 688 |
| Staff expenses | −506 | −28 | −49 |
| EBITDA | 545 | 346 | 482 |
| Depreciation & amort. | — | — | — |
| EBIT | 545 | 346 | 482 |
| Net financials | 9 | 12 | −1 |
| Profit before tax | 413 | 266 | 358 |
| Tax | −87 | −57 | −76 |
| Net profit | 326 | 210 | 282 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 800 | 793 | 822 |
| Equity | 351 | 361 | 342 |
| Long-term debt | — | — | — |
| Short-term debt | 308 | 199 | 124 |
| Total debt | 308 | 199 | 124 |
EBITDA margin
70.0%
This company
15.8%
Market median
+343% vs market
20232025
Equity ratio
41.6%
This company
38.2%
Market median
+9% vs market
20232025
Return on equity
82.2%
This company
18.4%
Market median
+347% vs market
20232025
Net profit margin
40.9%
This company
8.1%
Market median
+405% vs market
20232025
Asset turnover
0.84×
This company
1.12×
Market median
+25% vs market
20232025
Debt / equity
1.40×
This company
0.62×
Market median
-126% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2026 | |
| Chairman | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2026 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SAMTALSLABORATORIET AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eliel Koivisto Stenström | Deputy Board Member | 0 companies |
| Mats Sture Sigurd Paulsen | Board of Directors | 0 companies |
| Fanny Maria Margareta Paulsen | Deputy Board Member | 0 companies |
| Emma Elisabeth Stenström | Chairman | 0 companies |